Page Banner/Search

Institutional Biosafety Committee

The Institutional Biosafety Committee (IBC) ensures that research involving recombinant DNA and biological materials follows designated guidelines.  The IBC follows the guidelines established by the National Institutes of Health (NIH) Office of Biotechnology Activities and The Center for Disease Control (CDC).

Institutional Biosafety Committee Forms

Policy and Guidance

Educational Materials

Federal Guidance